Variant report
Variant | nsv521811 |
---|---|
Chromosome Location | chr3:20570373-20575986 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs1403651 | chr3:20570373-20570374 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs559775243 | chr3:20570390-20570391 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs574785315 | chr3:20570398-20570399 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs542220382 | chr3:20570410-20570411 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs34505379 | chr3:20570426-20570427 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs554059037 | chr3:20570433-20570434 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs1403650 | chr3:20570456-20570457 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs531256168 | chr3:20570481-20570482 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs111280050 | chr3:20570526-20570527 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs552872672 | chr3:20570560-20570561 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs144499210 | chr3:20570569-20570570 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs12636507 | chr3:20570634-20570635 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs146163578 | chr3:20570690-20570691 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs147328053 | chr3:20570697-20570698 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs547223712 | chr3:20570703-20570704 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs570933870 | chr3:20570738-20570739 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs374745657 | chr3:20570739-20570740 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs565757564 | chr3:20570743-20570744 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs139072890 | chr3:20570760-20570761 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs548171541 | chr3:20570788-20570789 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs555391803 | chr3:20570793-20570794 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs386659112 | chr3:20570797-20570798 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs1554572 | chr3:20570799-20570800 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs564084373 | chr3:20570841-20570842 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs1554571 | chr3:20570852-20570853 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs540454929 | chr3:20570871-20570872 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs576653425 | chr3:20570934-20570935 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs534811939 | chr3:20570937-20570938 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs552853893 | chr3:20570951-20570952 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs1554570 | chr3:20570962-20570963 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs5847057 | chr3:20570968-20570969 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs549220589 | chr3:20571023-20571024 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs541932547 | chr3:20571044-20571045 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs114703114 | chr3:20571057-20571058 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs575694145 | chr3:20571060-20571061 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs79538875 | chr3:20571071-20571072 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs80301313 | chr3:20571107-20571108 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs528720996 | chr3:20571131-20571132 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs540829316 | chr3:20571163-20571164 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs562093711 | chr3:20571172-20571173 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs35236290 | chr3:20571175-20571176 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs61474077 | chr3:20571199-20571200 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs536573271 | chr3:20575810-20575811 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs575819146 | chr3:20575925-20575926 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs1506048 | chr3:20575986-20575987 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Neuroblastoma | 17327916 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Melanoma | 18172304 | CNVD |
Cervical cancer | 21062161 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Retinoblastoma | 21504564 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Intellectual disability | 22102821 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Breast cancer | 17133270 | CNVD |
Developmental delay | 21147756 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Cancer | 20164919 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:20569000-20571200 | Enhancers | Fetal Intestine Small | intestine |
2 | chr3:20569200-20571200 | Enhancers | Fetal Intestine Large | intestine |
3 | chr3:20570000-20570400 | Weak transcription | Fetal Lung | lung |
4 | chr3:20570200-20571000 | Enhancers | Fetal Stomach | stomach |
5 | chr3:20570400-20571000 | Enhancers | Fetal Lung | lung |
6 | chr3:20575800-20578600 | Weak transcription | NHDF-Ad | bronchial |